SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-028128
Filing Date
2022-11-29
Accepted
2022-11-29 07:53:42
Documents
13
Period of Report
2022-11-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20221128_8k.htm   iXBRL 8-K 32432
  Complete submission text file 0001437749-22-028128.txt   165304

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA kmph-20221128.xsd EX-101.SCH 3603
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kmph-20221128_def.xml EX-101.DEF 11534
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE kmph-20221128_lab.xml EX-101.LAB 15416
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kmph-20221128_pre.xml EX-101.PRE 11690
7 EXTRACTED XBRL INSTANCE DOCUMENT kmph20221128_8k_htm.xml XML 2564
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 221428354
SIC: 2834 Pharmaceutical Preparations